ADC Therapeutics ADCT
NYSE ADCT
$1.52 +0.08 (+5.90%)
As of: Oct 20, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) Notes Payables (2022 - 2023)

Updated

ADC Therapeutics (ADCT) recorded Notes Payables of $14.33 million in Q3 2023, up 14.6% from $12.5 million a year earlier and up 3.1% from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Notes Payables (2022 - 2023) Analysis & Trends

At the end of FY2022, ADC Therapeutics reported Notes Payables of $12.47 million.

  • Per Business Quant, the preceding three quarters came in at $13.9 million (Q2 2023), $13.53 million (Q1 2023) and $12.47 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 ADC Therapeutics 235.62 Mn -710.57 Mn 16.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 14.33 Mn
Jun 30, 2023 13.90 Mn
Mar 31, 2023 13.53 Mn
Dec 31, 2022 12.47 Mn
Sep 30, 2022 12.50 Mn
API Access

ADC Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ADCT&period=max&api_key=YOUR_API_KEY